To investigate the relationship between CSC markers and the proliferative capacity of tumor, we first examined the proliferative capacity of the four breast cancer cell lines by checking the expression of antigen Ki67 that was an indicator normally used for proliferative capacity (Fig. 2A)41. This evidence concerns the gene MKI67 and breast carcinoma.